Williams BG

Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, De Mack CF, Williams P, Jones L, Smyth C, Kutch KA, Ying-Ru L, Vitoria M, Souteyrand Y, Crowley S, Korenromp EL, Williams BG

PLoS One

(2012)

https://doi.org/10.1371/journal.pone.0030216
Role of acute infection in HIV transmission
Williams BG, Granich R, Dye C

The Lancet

(2011)

https://doi.org/10.1016/S0140-6736(11)61832-1
Modelling the impact of antiretroviral therapy on the epidemic of HIV
Williams BG, Lima VD, Gouws E

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038533
Drug-resistant tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
Wallengren K, Scano F, Nunn P, Margot B, Buthelezi SSS, Williams BG, Pym A, Samuel EY, Mirzayev F, Nkhoma W, Mvusi L, Pillay Y

Emerging Infectious Diseases

(2011)

https://doi.org/10.3201/eid1710.100952
Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa
Williams BG, Abdool Karim SS, Karim QA, Gouws E

Journal of Acquired Immune Deficiency Syndromes

(2011)

https://doi.org/10.1097/QAI.0b013e3182253c19
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts
Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M, Hankins C, Schwartlander B, Ridzon R, Bazin B, Williams BG, Lo YR, McClure C, Montaner J, Hirnschall G, ART in Prevention of HIV TB Research Writing Group

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038597
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis
Granich R, Lo YR, Suthar AB, Vitoria M, Baggaley R, Obermeyer CM, McClure C, Souteyrand Y, Perriens J, Kahn JG, Bennett R, Smyth C, Williams BG, Montaner J, Hirnschall G

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038551
Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting
Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin ML, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Obermeyer CM, Mack CD, Williams P, Smyth C, Vitoria M, Crowley S, Williams BG, McClure C, Granich R, Hirnschall G

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038614
Cost-effectiveness of antiretroviral therapy for prevention
Kahn JG, Marseille EA, Bennett R, Williams BG, Granich R

Current HIV Research

(2011)

https://doi.org/10.2174/157016211798038542
Treatment-centred prevention: an integrated biomedical and social approach to HIV prevention
Delva W, Verguet S, Hargrove JW, Williams BG, Sheneberger R, Stander T, Welte A

AIDS

(2011)

https://doi.org/10.1097/QAD.0b013e3283488503
Treatment as prevention: preparing the way
Williams BG, Wood R, Dukay V, Delva W, Ginsburg D, Hargrove JW, Stander M, Sheneberger R, Montaner J, Welte A

Journal of the International AIDS Society

(2011)

https://doi.org/10.1186/1758-2652-14-S1-S6
Nutrition, diabetes and tuberculosis in the epidemiological transition
Dye C, Bourdin TB, L?nnroth K, Roglic G, Williams BG

PLoS One

(2011)

https://doi.org/10.1371/journal.pone.0021161
Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe
Hargrove JW, Humphrey JH, Mahomva A, Williams BG, Chidawanyika H, Mutasa K, Marinda ET, Mbizvo MT, Nathoo KJ, Iliff PJ, Mugurungi O, ZVITAMBO Study Group

Epidemics

(2011)

https://doi.org/10.1016/j.epidem.2011.02.004
How different are the costs and consequences of delayed versus immediate HIV treatment?
Welte A, Hargrove JW, Delva W, Williams BG, Stander T

South African Medical Journal

(2011)

http://www.samj.org.za/index.php/samj/article/viewFile/4700/3235
Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?
Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R

International Journal of Tuberculosis and Lung Disease

(2011)

https://doi.org/10.5588/ijtld.10.0483
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality
Glaziou P, Floyd K, Korenromp EL, Sismanidis C, Bierrenbach AL, Williams BG, Atun R, Raviglione M

Bulletin of The World Health Organization

(2011)

https://doi.org/10.2471/BLT.11.087510
Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review
Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke N

PLoS One

(2011)

https://doi.org/10.1371/journal.pone.0017601
Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings
Lawn SD, Ayles H, Egwaga S, Williams BG, Mukadi Y D, Santos Filho ED, Godfrey-Faussett P, Granich RM, Harries AD

International Journal of Tuberculosis and Lung Disease

(2011)

http://www.ncbi.nlm.nih.gov/pubmed/21333094
Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?
Johnstone-Robertson S, Hargrove JW, Williams BG

HIV/AIDS - Research And Palliative Care 3

(2011)

https://doi.org/10.2147/HIV.S7278
Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial
Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, Churchyard GJ, Williams BG, Munyati SS, Butterworth AE, Mason PR, Mungofa S, Hayes RJ

The Lancet

(2010)

https://doi.org/10.1016/S0140-6736(10)61425-0
Highly active antiretroviral treatment as prevention of HIV transmission
Granich R, Crowley S, Vitoria M, Lo YR, Souteyrand Y, Dye C, Gilks C, Guerma T, De Cock KM, Williams BG

Journal of the International AIDS Society

(2010)

https://doi.org/10.1186/1758-2652-13-1
The benefits of early treatment for HIV
Williams BG, Hargrove JW, Humphrey JH

AIDS

(2010)

https://doi.org/10.1097/QAD.0b013e32833ac860
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, Lo Y, Souteyrand Y, Williams BG

Current opinion in HIV and AIDS

(2010)

https://doi.org/10.1097/coh.0b013e32833a6c32
Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count?
Ferrand RA, Lowe S, Whande B, Munaiwa L, Langhaug L, Cowan F, Mugurungi O, Gibb D, Munyati SS, Williams BG, Corbett EL

Bulletin of The World Health Organization

(2010)

https://doi.org/10.2471/BLT.09.066126
The HIV-associated tuberculosis epidemic-when will we act?
Harries AD, Zacariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM

The Lancet

(2010)

https://doi.org/10.1016/s0140-6736(10)60409-6

Previous 234 Next

Williams BG

Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050

Role of acute infection in HIV transmission

Modelling the impact of antiretroviral therapy on the epidemic of HIV

Drug-resistant tuberculosis, KwaZulu-Natal, South Africa, 2001–2007

Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa

Antiretroviral therapy in prevention of HIV and TB: update on current research efforts

Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis

Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting

Cost-effectiveness of antiretroviral therapy for prevention

Treatment-centred prevention: an integrated biomedical and social approach to HIV prevention

Treatment as prevention: preparing the way

Nutrition, diabetes and tuberculosis in the epidemiological transition

Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe

How different are the costs and consequences of delayed versus immediate HIV treatment?

Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality

Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review

Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings

Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives?

Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial

Highly active antiretroviral treatment as prevention of HIV transmission

The benefits of early treatment for HIV

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count?

The HIV-associated tuberculosis epidemic-when will we act?

Type

Year

Author